SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-011609
Filing Date
2018-08-14
Accepted
2018-08-14 07:35:22
Documents
13
Period of Report
2018-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 32724
2 ex99-1.htm EX-99.1 94401
3 ex99-2.htm EX-99.2 9648
4 ex99-2_001.jpg GRAPHIC 95465
5 ex99-2_002.jpg GRAPHIC 138648
6 ex99-2_003.jpg GRAPHIC 80190
7 ex99-2_004.jpg GRAPHIC 72418
8 ex99-2_005.jpg GRAPHIC 87568
9 ex99-2_006.jpg GRAPHIC 106354
10 ex99-2_007.jpg GRAPHIC 98254
11 ex99-2_008.jpg GRAPHIC 105938
12 ex99-2_009.jpg GRAPHIC 100410
13 ex99-2_010.jpg GRAPHIC 139896
  Complete submission text file 0001493152-18-011609.txt   1550942
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 181014272
SIC: 8071 Services-Medical Laboratories
Assistant Director 9